Literature DB >> 21184952

Low high density lipoprotein cholesterol: prevalence and associated risk-factors in a large French population.

Marion Rouvre1, Sylviane Vol, Gaëlle Gusto, Catherine Born, Olivier Lantieri, Jean Tichet, Pierre Lecomte.   

Abstract

PURPOSE: High density lipoprotein-cholesterol (HDL-C) is a strong predictor of cardiovascular risk. We investigated the distribution of HDL-C in a French general population according to age, sex, and the risk factors associated with low HDL-C values.
METHODS: A group of 18,483 men and 22,047 women 16-79 years of age were investigated during a medical check-up. Relevant parameters were studied in three groups according to age and gender-specific percentile classes (≤5th [HDL₅] median and >95th). Gender-specific logistic regression models selected variables associated with HDL₅.
RESULTS: Using the National Cholesterol Education Program Adult Treatment Panel III criteria (threshold: 40 mg/dL in men, 50 mg/dL in women) the prevalence of low HDL-C was 11.1% and 26.4% in men and women and it decreased with age. Mean HDL-C levels increased with age. HDL₅ was positively associated with a sedentary lifestyle and deprivation (p < 0.00001) even after adjustment on alcohol consumption and smoking. Abdominal obesity, smoking, hypertriglyceridemia, hyperleucocytosis, and low alcohol consumption were associated with HDL₅ for both genders.
CONCLUSIONS: The prevalence of low HDL-C was similar to that observed in other Europeans but lower than in the United States. HDL₅ was associated with cardiovascular risk factors, metabolic syndrome, and social deprivation. A prevention policy to increase HDL-C levels should focus on reducing smoking and abdominal obesity, particularly in deprived subjects.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21184952     DOI: 10.1016/j.annepidem.2010.07.097

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  5 in total

1.  What intervention trials don't tell us: the residual risk in primary prevention.

Authors:  Claudio Cimminiello
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  Smoking Status and Metabolic Syndrome in the Multi-Ethnic Study of Atherosclerosis. A cross-sectional study.

Authors:  Ivan Berlin; Susan Lin; Joao A C Lima; Alain Gerald Bertoni
Journal:  Tob Induc Dis       Date:  2012-06-20       Impact factor: 2.600

3.  Coexistence of High Fibrinogen and Low High-density Lipoprotein Cholesterol Levels Predicts Recurrent Cerebral Venous Thrombosis.

Authors:  Xin Ma; Xun-Ming Ji; Paul Fu; Yu-Chuan Ding; Qiang Xue; Yue Huang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

4.  Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea.

Authors:  Hyunjung Lim; Tuan Nguyen; Ryowon Choue; Youfa Wang
Journal:  Diabetes Care       Date:  2012-07-26       Impact factor: 19.112

5.  Does the low-density lipoprotein cholesterol play a key role in predicting metabolic syndrome in the Iranian adult population?

Authors:  Karimollah Hajian-Tilaki; Behzad Heidari; Arefeh Hajian-Tilaki; Alireza Firouzjahi; Afsaneh Bakhtiari
Journal:  Caspian J Intern Med       Date:  2017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.